Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Puopolo

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Trials|November 17, 2023
The Promotoer, a brain-computer interface-assisted intervention to promote upper limb functional motor recovery after stroke: a statistical analysis plan for a randomized controlled trialMarta Cipriani, Floriana Pichiorri, Emma Colamarino, et al.
Transfusion|November 16, 2011
Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutionsFranco Cardone, Steve Simoneau, Aude Arzel, et al.
Journal of Virology|March 17, 2017
Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob DiseaseRoberta Galeno, Michele Angelo Di Bari, Romolo Nonno, et al.
Trials|December 5, 2023
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trialFlavia L Lombardo, Stefania Spila Alegiani, Flavia Mayer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 25, 2021
Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021Alberto Mateo-Urdiales, Stefania Spila Alegiani, Massimo Fabiani, et al.
Biopreservation and Biobanking|July 31, 2014
Development of a pilot project on data sharing among partners of the Italian Hub of Population Biobanks (HIBP): association between lipid profile and socio-demographic variablesMariarosaria Napolitano, Filippo Santoro, Maria Puopolo, et al.
BMC Public Health|November 14, 2006
Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002Jesús de Pedro-Cuesta, Markus Glatzel, Javier Almazán, et al.
BMJ (Clinical Research Ed.)|February 11, 2022
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort studyMassimo Fabiani, Maria Puopolo, Cristina Morciano, et al.
Human Genetics|September 28, 2005
Genetic prion disease: the EUROCJD experienceGábor G Kovács, Maria Puopolo, Anna Ladogana, et al.
Expert Review of Vaccines|April 7, 2022
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021Massimo Fabiani, Maria Puopolo, Antonietta Filia, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Trials|November 17, 2023
The Promotoer, a brain-computer interface-assisted intervention to promote upper limb functional motor recovery after stroke: a statistical analysis plan for a randomized controlled trialMarta Cipriani, Floriana Pichiorri, Emma Colamarino, et al.
Transfusion|November 16, 2011
Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutionsFranco Cardone, Steve Simoneau, Aude Arzel, et al.
Journal of Virology|March 17, 2017
Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob DiseaseRoberta Galeno, Michele Angelo Di Bari, Romolo Nonno, et al.
Trials|December 5, 2023
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trialFlavia L Lombardo, Stefania Spila Alegiani, Flavia Mayer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 25, 2021
Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021Alberto Mateo-Urdiales, Stefania Spila Alegiani, Massimo Fabiani, et al.
Biopreservation and Biobanking|July 31, 2014
Development of a pilot project on data sharing among partners of the Italian Hub of Population Biobanks (HIBP): association between lipid profile and socio-demographic variablesMariarosaria Napolitano, Filippo Santoro, Maria Puopolo, et al.
BMC Public Health|November 14, 2006
Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002Jesús de Pedro-Cuesta, Markus Glatzel, Javier Almazán, et al.
BMJ (Clinical Research Ed.)|February 11, 2022
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort studyMassimo Fabiani, Maria Puopolo, Cristina Morciano, et al.
Human Genetics|September 28, 2005
Genetic prion disease: the EUROCJD experienceGábor G Kovács, Maria Puopolo, Anna Ladogana, et al.
Expert Review of Vaccines|April 7, 2022
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021Massimo Fabiani, Maria Puopolo, Antonietta Filia, et al.
Pageof 7